Akebia Therapeutics, Inc. posts $-92.56 million annual loss
By USInMinutes
Published - Mar 11, 2023, 04:27 AM ET
Last Updated - Jul 18, 2023, 04:21 PM EDT
Akebia Therapeutics, Inc. [AKBA] has posted annual loss of $-92.56 million for the year ended Dec 31,2022.
The company based in Massachusetts(MA)reported a risein revenue to $292.60 milion for the year when compared to $213.58 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 10,2023 showed that its revenue is up 37.00% year-over-year.
The company reported basic earnings per share of $182782680 and diluted earnings per share of $182782680.
Akebia Therapeutics, Inc. operates in the Pharmaceutical Preparations sector.
Related News
Healthcare-conference">➤Akebia Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference
--------
NewsInMinutes: is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts.
